Prokidney Corp Stock Performance
| PROK Stock | USD 1.67 0.12 6.70% |
ProKidney Corp has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.57, which implies possible diversification benefits within a given portfolio. As returns on the market increase, ProKidney Corp's returns are expected to increase less than the market. However, during the bear market, the loss of holding ProKidney Corp is expected to be smaller as well. ProKidney Corp right now holds a risk of 6.29%. Please check ProKidney Corp value at risk, as well as the relationship between the skewness and day median price , to decide if ProKidney Corp will be following its historical price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in ProKidney Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, ProKidney Corp may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
Last Split Factor 1:1 | Last Split Date 2022-07-12 |
1 | Disposition of 137000 shares by Darin Weber of ProKidney Corp subject to Rule 16b-3 | 11/05/2024 |
2 | Morgan Stanleys Strategic Reduction in ProKidney Corp Holdings | 11/08/2024 |
3 | ProKidney Shares Up 7.8 percent Heres What Happened | 11/15/2024 |
4 | ProKidney Manufacturing expansion moving to W-S instead of GSO, | 11/19/2024 |
5 | ProKidney to Participate in Two Upcoming Conferences Evercore HealthCONx Conference and the Citi Global Healthcare Conference | 11/26/2024 |
6 | Disposition of 79600 shares by Palihapitiya Chamath of ProKidney Corp at 1.5555 subject to Rule 16b-3 | 12/06/2024 |
7 | ProKidney Stock Price Down 2.5 percent - Heres What Happened - MarketBeat | 12/26/2024 |
8 | Acquisition by Fox Jennifer A. of 42515 shares of ProKidney Corp at 10.92 subject to Rule 16b-3 | 12/27/2024 |
9 | Stories to Watch in 2025 Will ProKidney change its Winston-Salem plans after abandoning 458M Greensboro facility | 01/02/2025 |
10 | ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference | 01/07/2025 |
| Begin Period Cash Flow | 490.3 M | |
| Free Cash Flow | -124.3 M |
ProKidney |
ProKidney Corp Relative Risk vs. Return Landscape
If you would invest 173.00 in ProKidney Corp on October 24, 2024 and sell it today you would lose (6.00) from holding ProKidney Corp or give up 3.47% of portfolio value over 90 days. ProKidney Corp is currently generating 0.1424% in daily expected returns and assumes 6.2851% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than ProKidney, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ProKidney Corp Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProKidney Corp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ProKidney Corp, and traders can use it to determine the average amount a ProKidney Corp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0227
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | PROK | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.29 actual daily | 56 56% of assets are less volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average ProKidney Corp is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProKidney Corp by adding it to a well-diversified portfolio.
ProKidney Corp Fundamentals Growth
ProKidney Stock prices reflect investors' perceptions of the future prospects and financial health of ProKidney Corp, and ProKidney Corp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProKidney Stock performance.
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | (171.31 M) | ||||
| Shares Outstanding | 127.97 M | ||||
| Price To Book | 91.32 X | ||||
| EBITDA | (147.67 M) | ||||
| Net Income | (135.45 M) | ||||
| Cash And Equivalents | 21.88 M | ||||
| Cash Per Share | 0.36 X | ||||
| Total Debt | 4.41 M | ||||
| Debt To Equity | 5.66 % | ||||
| Current Ratio | 0.74 X | ||||
| Book Value Per Share | (7.66) X | ||||
| Cash Flow From Operations | (90.07 M) | ||||
| Earnings Per Share | (0.54) X | ||||
| Market Capitalization | 1.81 B | ||||
| Total Asset | 420.55 M | ||||
| Retained Earnings | (1.14 B) | ||||
| Working Capital | 349.11 M | ||||
About ProKidney Corp Performance
By examining ProKidney Corp's fundamental ratios, stakeholders can obtain critical insights into ProKidney Corp's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that ProKidney Corp is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.34) | (0.36) | |
| Return On Assets | (0.08) | (0.08) | |
| Return On Equity | 0.03 | 0.03 |
Things to note about ProKidney Corp performance evaluation
Checking the ongoing alerts about ProKidney Corp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ProKidney Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ProKidney Corp had very high historical volatility over the last 90 days | |
| ProKidney Corp may become a speculative penny stock | |
| ProKidney Corp has high likelihood to experience some financial distress in the next 2 years | |
| ProKidney Corp currently holds 4.41 M in liabilities with Debt to Equity (D/E) ratio of 5.66, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. ProKidney Corp has a current ratio of 0.73, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about ProKidney Corp's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (135.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ProKidney Corp currently holds about 21.88 M in cash with (90.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| ProKidney Corp has a very weak financial position based on the latest SEC disclosures | |
| Roughly 27.0% of ProKidney Corp outstanding shares are owned by corporate insiders | |
| Latest headline from gurufocus.com: ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
- Analyzing ProKidney Corp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ProKidney Corp's stock is overvalued or undervalued compared to its peers.
- Examining ProKidney Corp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ProKidney Corp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ProKidney Corp's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ProKidney Corp's stock. These opinions can provide insight into ProKidney Corp's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProKidney Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. If investors know ProKidney will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProKidney Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ProKidney Corp is measured differently than its book value, which is the value of ProKidney that is recorded on the company's balance sheet. Investors also form their own opinion of ProKidney Corp's value that differs from its market value or its book value, called intrinsic value, which is ProKidney Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProKidney Corp's market value can be influenced by many factors that don't directly affect ProKidney Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProKidney Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProKidney Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProKidney Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.